Anticancer Therapies – News and Features
Study Provides New Information for Blood Cancer Treatment During Pregnancy
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers, yet prior to this study, no data existed to inform these choices.
Antioxidant Enzymes Repair DNA Damage
In crisis, the nucleus calls antioxidant enzymes to the rescue. The nucleus being metabolically active is a profound paradigm shift with implications for cancer research.
New Cancer Immunotherapy Approach Improves Efficacy and Side Effects in Mice
Scientists have discovered a novel approach that improves the efficacy of immune checkpoint inhibitor cancer treatment and minimizes the associated side effects.
Two-Pronged Cell Therapy Targets Melanoma Spread to the Brain
A two-pronged stem cell therapy has been developed in a new study, which shows can suppress tumor growth and prolong survival in preclinical animal models.
Life Expectancy of Children With Brain Cancer Extended With Novel Drug Combination
Researchers have discovered a drug combination that could dramatically improve the life expectancy of children living with brain cancer.
Personalized mRNA Vaccine Could Be Used To Treat Pancreatic Cancer
An research team have been developing a personalized mRNA cancer-treatment vaccine approach. It is designed to help immune cells recognize specific neoantigens on patients’ pancreatic cancer cells.
Cancers in Far-Off Organs Can Alter Liver Function
Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions.
Lipid Metabolism Insights Could Unlock Treatment for Aggressive Brain Cancer
A study has shown how a mutation found in the majority of glioblastomas, an aggressive brain cancer, alters lipid metabolism and could open up new avenues for treatment.
Study Finds Method To Make Glioblastoma Cells "Self-Destruct"
Researchers have developed a method that can kill the aggressive brain tumor glioblastoma in animal models. By blocking certain functions in the cell with a docked molecule, the researchers caused cancer cells to die of stress.
Promising Results From Small Trial of Drug Combination for Glioblastoma
Improvements in 6-month progression-free survival may warrant additional study in a larger trial.